BLRX
BioLineRx Ltd
NASDAQ: BLRX · HEALTHCARE · BIOTECHNOLOGY
$2.79
-9.12% today
Updated 2026-04-30
Market cap
$10.21M
P/E ratio
0.00
P/S ratio
8.66x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$2 – $8
Volume
0.0M
BioLineRx Ltd (BLRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-99.60%
Operating margin
-1,745.00%
ROE
-11.00%
ROA
-16.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-32.06M | — | — | — |
| 2009 | $16.27M | $-15.66M | 61.86% | -99.02% | -96.26% |
| 2010 | $31.89M | $2.10M | 77.40% | 11.61% | 6.57% |
| 2011 | $63.91M | $-13.19M | -0.68% | -25.61% | -20.63% |
| 2012 | $113.16M | $-20.42M | -0.35% | -18.69% | -18.04% |
| 2013 | $113.16M | $-17.64M | -0.28% | -15.03% | -15.59% |
| 2014 | $0.00 | $-10.17M | — | — | — |
| 2015 | $0.00 | $-14.40M | — | — | — |
| 2016 | $0.00 | $-15.84M | — | — | — |
| 2017 | $0.00 | $-24.35M | — | — | — |
| 2018 | $0.00 | $-22.96M | — | — | — |
| 2019 | $0.00 | $-25.45M | — | — | — |
| 2020 | $0.00 | $-30.02M | — | — | — |
| 2021 | $0.00 | $-27.05M | — | — | — |
| 2022 | $0.00 | $-24.95M | — | — | — |
| 2023 | $4.80M | $-60.61M | 23.08% | -1,035.29% | -1,262.79% |
| 2024 | $28.94M | $-9.22M | 67.99% | -70.52% | -31.86% |
| 2025 | $1.19M | $-1.18M | 36.19% | -871.78% | -99.58% |